Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors
Author:
Funder
California Breast Cancer Research Program
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/article/10.1007/s10549-018-05086-8/fulltext.html
Reference29 articles.
1. Previtali E, Bucciarelli P, Passamonti SM, Martinelli I (2011) Risk factors for venous and arterial thrombosis. Blood Transfus 9(2):120–138
2. Cushman M (2007) Epidemiology and risk factors for venous thrombosis. Semin Hematol 44(2):62–69
3. Prandoni P, Falanga A, Piccioli A (2005) Cancer and venous thromboembolism. Lancet Oncol 6(6):401–410
4. Van de Velde CJH, Rea D et al (2011) Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial. Lancet 377(9762):321–331
5. Levine MN (2007) Adjuvant therapy and thrombosis: how to avoid the problem? The Breast 16(Suppl 2):169–174
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Venous thromboembolism in women with hormone-dependent breast cancer. To continue or discontinue hormonal treatment? Insights from the RIETE registry;Thrombosis Research;2024-09
2. Venous thromboembolism associated with medically assisted reproduction (MAR): British fertility society policy and practice guidance for assessment and prevention;Human Fertility;2024-05-28
3. Venous thromboembolism in pregnancy and postpartum: an illustrated review;Research and Practice in Thrombosis and Haemostasis;2024-05
4. Lomitapide as a Potential Estrogen Receptor Inhibitor: A Computational Drug Repurposing Study;Kocaeli Üniversitesi Sağlık Bilimleri Dergisi;2024-03-15
5. Contraception for antiphospholipid syndrome and systemic lupus erythematosus (according to the recommendations of the European Alliance of Associations for Rheumatology/American College of Rheumatology, EULAR/ACR);Rheumatology Science and Practice;2024-02-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3